1. Home
  2. SBET vs PCRX Comparison

SBET vs PCRX Comparison

Compare SBET & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SharpLink Gaming Ltd.

SBET

SharpLink Gaming Ltd.

SELL

Current Price

$5.18

Market Cap

1.2B

Sector

Technology

ML Signal

SELL

Logo Pacira BioSciences Inc.

PCRX

Pacira BioSciences Inc.

SELL

Current Price

$36.49

Market Cap

1.5B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
SBET
PCRX
Founded
1995
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.5B
IPO Year
2025
2010

Fundamental Metrics

Financial Performance
Metric
SBET
PCRX
Price
$5.18
$36.49
Analyst Decision
Strong Buy
Hold
Analyst Count
8
9
Target Price
$16.13
★ $33.57
AVG Volume (30 Days)
★ 9.4M
944.4K
Earning Date
11-06-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 107.44
EPS
N/A
★ 0.89
Revenue
$28,055,000.00
★ $541,533,000.00
Revenue This Year
$81.28
$3.84
Revenue Next Year
$47.36
$4.73
P/E Ratio
★ N/A
$40.99
Revenue Growth
★ 666.04
26.04
52 Week Low
$4.46
$18.80
52 Week High
$12.29
$36.67

Technical Indicators

Market Signals
Indicator
SBET
PCRX
Relative Strength Index (RSI) 27.32 82.36
Support Level $5.06 $22.00
Resistance Level $5.90 $36.67
Average True Range (ATR) 0.38 0.04
MACD -0.10 -0.38
Stochastic Oscillator 4.79 86.67

Price Performance

Historical Comparison
SBET
PCRX

About SBET SharpLink Gaming Ltd.

Sharplink Inc is one of those publicly traded companies to adopt ETH as its primary treasury reserve asset. This move reflects the Company's commitment to align corporate treasury with the future of programmable finance, digital capital markets, and decentralized infrastructure. The Company also operates an online affiliate marketing company that delivers different fan activation solutions to its sportsbook and online casino gaming partners. The company operates in two reportable segments: ETH Treasury Management and Affiliate Marketing. The majority of its revenue is generated from the ETH Treasury Management. Geographically, the company operates in the United States and the rest of the world.

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

Share on Social Networks: